This article is filed under: dengue, Dengvaxia, died of severe dengue, DOH, health, health risk, Philipines, Sanofi, Vaccine, Health Current Events, Health, Article About Health, Health Issues, Health Problems
Source:
This article is filed under: dengue, Dengvaxia, died of severe dengue, DOH, health, health risk, Philipines, Sanofi, Vaccine, Health Current Events, Health, Article About Health, Health Issues, Health Problems
Advertisements
After the expose of the controversy on the questionable effect of Dengvaxia, victims started to surface attesting to the adverse effect of the vaccine and some children has actually died.
In October last year, a Grade 5 student in Mariveles, Bataan, died of severe dengue, months after receiving a shot of Dengvaxia.
Read: More than 700 Filipino children at risk after receiving anti-dengue vaccine.
Christine Mae de Guzman, who had not been infected by dengue, developed severe headache and fever on October 11, rushed to the Bataan General Hospital on October 14, and on October 15 she passed away. She got her first Dengvaxia shot in April.
The Sisiman Elementary School student's death certificate stated that she died due to disseminated intravascular coagulopathy and severe dengue.
Marivic and Nelson, Christine Mae's parents, believe that her condition was caused by the vaccine. They seek for justice especially after Sanofi Pasteur, Dengvaxia's manufacturer, admitted that the vaccine may worsen the disease in people who have not been previously infected by dengue.
Report said that Marivic and Nelson signed a parental consent form before their daughter was given the anti-dengue vaccination.
The Volunteers Against Crime and Corruption (VACC) will present De Guzman's death in the class action lawsuit it hopes to file against those involved on the controversial P3.5-billion dengue vaccination program of the Department of Health (DOH).
Prior to De Guzman's case, the death of an 11-year-old student who supposedly died after receiving the anti-dengue vaccine was brought up in a Senate blue ribbon committee investigation on the program in 2016.
Meanwhile, student Amy Tamayo from Tarlac reportedly contracted dengue despite receiving her third dose of Dengvaxia last August.
Christine Mae de Guzman, who had not been infected by dengue, developed severe headache and fever on October 11, rushed to the Bataan General Hospital on October 14, and on October 15 she passed away. She got her first Dengvaxia shot in April.
The Sisiman Elementary School student's death certificate stated that she died due to disseminated intravascular coagulopathy and severe dengue.
Marivic and Nelson, Christine Mae's parents, believe that her condition was caused by the vaccine. They seek for justice especially after Sanofi Pasteur, Dengvaxia's manufacturer, admitted that the vaccine may worsen the disease in people who have not been previously infected by dengue.
Report said that Marivic and Nelson signed a parental consent form before their daughter was given the anti-dengue vaccination.
The Volunteers Against Crime and Corruption (VACC) will present De Guzman's death in the class action lawsuit it hopes to file against those involved on the controversial P3.5-billion dengue vaccination program of the Department of Health (DOH).
Prior to De Guzman's case, the death of an 11-year-old student who supposedly died after receiving the anti-dengue vaccine was brought up in a Senate blue ribbon committee investigation on the program in 2016.
Meanwhile, student Amy Tamayo from Tarlac reportedly contracted dengue despite receiving her third dose of Dengvaxia last August.
Sponsored Links
Advertisement
This article is filed under: dengue, Dengvaxia, died of severe dengue, DOH, health, health risk, Philipines, Sanofi, Vaccine, Health Current Events, Health, Article About Health, Health Issues, Health Problems
Read More:
©2017 THOUGHTSKOTO
SEARCH JBSOLIS, TYPE KEYWORDS and TITLE OF ARTICLE at the box below